Provention Bio Inc. (PRVB)

Name: Provention Bio Inc. (PRVB) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Provention Bio Inc. (PRVB)

Stock Card

$24.98

$0.00 (0.00%)

As on 27-Apr-2023 09:30EDT

Market cap

$2,375 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

P/B Ratio

5.3

Div. Yield

0 %

Provention Bio (PRVB) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 24.98 High: 24.98

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-80 Mln
ROE

-1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-5.4
Debt to Equity

0.2
Book Value

$1.6
EPS

$-1.5
Face value

--
Shares outstanding

91,100,400

7 Years Aggregate

CFO

$-315.60 Mln

EBITDA

$-375.19 Mln

Net Profit

$-404.55 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Provention Bio (PRVB)	136.3	4.6	186.8	396.6	27.4	--	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Apr-2023 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2022	2021	2020	2019
Provention Bio (PRVB)	88.1	-66.8	13.7	741.8
S&P Small-Cap 600	-17.4	25.3	9.6	20.9
BSE Sensex	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Provention Bio (PRVB)	25.0	2,375.4	12.9	-113.6	-993.9	133.4	--	5.3
Chembio Diagnostics (CEMI)	0.5	16.7	48.3	-23.3	-42.2	-89.5	--	0.7

Shareholding Pattern

View Details

About Provention Bio (PRVB)

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and... monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Read more

Co-Founder, Pres, CEO & Director

Mr. Ashleigh W. Palmer B.Sc., M.B.A.
Co-Founder, Pres, CEO & Director

Mr. Ashleigh W. Palmer B.Sc., M.B.A.
Headquarters

Red Bank, NJ
Website

https://www.proventionbio.com

FAQs for Provention Bio (PRVB)

What is the current share price of Provention Bio Inc (PRVB) Today?

The share price of Provention Bio Inc (PRVB) is $24.98 (NASDAQ) as of 27-Apr-2023 09:30 EDT. Provention Bio Inc (PRVB) has given a return of 27.4% in the last 3 years.

What is the current PB & PE ratio of Provention Bio Inc (PRVB)?

Since, TTM earnings of Provention Bio Inc (PRVB) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-6.98	6.51
2021	-3.09	-1.21
2020	-8.94	-4.96
2019	-14.48	-7.73
2018	-1.47	0.65

What is the 52 Week High and Low of Provention Bio Inc (PRVB)?

The 52-week high and low of Provention Bio Inc (PRVB) are Rs -- and Rs -- as of 31-Aug-2026.

What is the market cap of Provention Bio Inc (PRVB)?

Provention Bio Inc (PRVB) has a market capitalisation of $ 2,375 Mln as on 27-Apr-2023. As per SEBI classification, it is a Small Cap company.

Should I invest in Provention Bio Inc (PRVB)?

Before investing in Provention Bio Inc (PRVB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.